Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 952 of 6351
-
Ultrasound device vs. blood thinners: which saves more lives from lung clots?
Disease control OngoingThere are many available treatments for pulmonary embolism (PE), but the best treatment for this condition is not known. The HI-PEITHO study will compare two treatment options that are both available on the market for the treatment of PE. Patients will be randomized 1:1 to recei…
Phase 4 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New vaccine combo aims to outsmart aggressive childhood cancer
Disease control Recruiting nowThe purpose of the study is to explore the combination of a bivalent vaccine, a sugar called beta-glucan (β-glucan), and a protein called granulocyte-macrophage colony stimulating factor (GM-CSF) as an effective treatment for people with high-risk neuroblastoma that is in complet…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can one surgery treat endometrial cancer and obesity together?
Disease control Recruiting nowTo assess the feasibility of an expedited referral process for the obese endometrial cancer or EIN patient from her gynecologic oncologist to the Brigham Center for Metabolic and Bariatric Surgery (CMBS) in order to undergo concurrent weight loss surgery and hysterectomy within 8…
Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Eye scan could spot hidden brain injury in seconds
Diagnosis CompletedRebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed trau…
Sponsor: Rebiscan, Inc. • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
Protein plus exercise: a recipe to rebuild muscle while losing fat in older age?
Disease control CompletedThis study aims to investigate if protein supplementation increases the benefits of exercise training in the elderly with sarcopenic obesity undergoing caloric restriction.
Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug could stop absence seizures without extra meds
Disease control CompletedThe purpose of the study is to test the efficacy, safety and tolerability of brivaracetam monotherapy in study participants 2 to 25 years of age inclusive with childhood absence epilepsy (CAE) or juvenile absence epilepsy (JAE).
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New drug combo shows promise for Tough-to-Treat leukemia in younger patients
Disease control CompletedThis phase II trial studies how well liposome-encapsulated daunorubicin-cytarabine (CPX-351) works in treating patients with secondary acute myeloid leukemia who are younger than 60 years old. Drugs used in chemotherapy, such as CPX-351, work in different ways to stop the growth …
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a Decades-Old parasite drug help fight pancreatic cancer?
Disease control OngoingThis phase I trial studies the side effects and best dose of pyrvinium pamoate for the treatment of pancreatic ductal adenocarcinoma that cannot be removed by surgery (resectable). Pyrvinium pamoate may slow down tumor growth and help patients live longer.
Phase 1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Fertility breakthrough? new additive may boost IVF success
Symptom relief OngoingDemonstrate the improvement of the live births rate after ICSI by supplementing the pre-ICSI incubation medium of oocytes and that of preimplantation embryos with cpFT at the 1st embryo transfer for women under 37 years old.
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New Four-Drug cocktail aims to tackle tough myeloma
Disease control OngoingThis phase II trial studies the effect of isatuximab, carfilzomib, pomalidomide, and dexamethasone in treating patients with multiple myeloma that has come back (relapsed) or does not respond to treatment (refractory). Isatuximab is a monoclonal antibody that may interfere with t…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Half a million people join quest to decode Parkinson's risk
Knowledge-focused Recruiting nowParkinson Progression Marker Initiative Online (PPMI Online) is an observational study collecting participant reported information from people with and without Parkinson's disease (PD), for the goal of better understanding risk and predictive factors for PD. PPMI Online is part …
Sponsor: Michael J. Fox Foundation for Parkinson's Research • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
New drug cocktail aims to extend life in advanced esophageal cancer
Disease control Stopped earlyThe purpose of this study is to assess the efficacy and safety of pembrolizumab plus lenvatinib plus chemotherapy compared with pembrolizumab plus chemotherapy as first-line intervention in participants with metastatic esophageal carcinoma. The primary hypotheses are that pembro…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New combo aims to keep cancer fluid at bay
Disease control OngoingMalignant Pleural Effusion or Ascites is a common complication of malignant tumor, The objective of this study is to compare the efficacy of Endostar/cisplatin with placebo/cisplatin in patients with malignant pleural effusion or ascites.
Phase 3 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New daily shot could free hypoparathyroidism patients from pills
Disease control CompletedThis study is limited to conduct in China only. The primary objective is to assess the treatment effect of daily TransCon PTH on serum calcium (sCa) levels within the normal range and stopping from therapeutic doses of active vitamin D (calcitriol) or active vitamin D analogue (a…
Phase 3 • Sponsor: Visen Pharmaceuticals (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New drug iptacopan aims to protect kidneys in rare C3G disease
Disease control Recruiting nowThe Primary Completion Date and Study Completion Date have been updated to reflect completion of the adolescent cohort, which has been added to the protocol. The study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate th…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for myeloma: targeted drug combo takes on Tough-to-Treat cancer
Disease control OngoingThis study is designed to evaluate safety and efficacy of belantamab mafodotin in combination with bortezomib/dexamethasone versus daratumumab in combination with bortezomib/dexamethasone in the Japanese participants with relapsed refractory multiple myeloma.
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heart scarring may begin before symptoms — could early valve replacement stop it?
Knowledge-focused CompletedAortic stenosis is narrowing of the aortic valve, and is the commonest type of valve disease requiring surgery. Current guidelines recommend waiting till patients develop symptoms (chest pain, breathlessness and dizzy spells/fainting) before possible open heart surgery to replace…
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Can a drop of blood predict disease years before it strikes?
Knowledge-focused Recruiting nowThe Health for Hungary (H4H) study collects blood samples and corresponding health data to investigate healthy aging and health-to-disease transitions in middle-aged and elderly participants. Indications Studied: Apparently healthy, symptom-free participants are enrolled and fo…
Sponsor: Center for Molecular Fingerprinting Research Nonprofit LLC • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Targeted drug shows promise for hard-to-treat stomach cancers
Disease control CompletedTreating Gastric Cancer and Esophagogastric junction adenocarcinoma Patients with MET gene amplifications with Savolitinib
Phase 2 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Hospital-Based program aims to break cycle of gun violence
Prevention Recruiting nowThe purpose of this research study is to find out if a hospital-based violence intervention (Bridging the Gap) is effective for reducing violence. The researchers think that adults who receive Bridging the Gap will see greater improvements than those who do not receive the interv…
Sponsor: Virginia Commonwealth University • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC